198 related articles for article (PubMed ID: 27886033)
1. Efficacy of lytic Staphylococcus aureus bacteriophage against multidrug-resistant Staphylococcus aureus in mice.
Oduor JM; Onkoba N; Maloba F; Arodi WO; Nyachieo A
J Infect Dev Ctries; 2016 Nov; 10(11):1208-1213. PubMed ID: 27886033
[TBL] [Abstract][Full Text] [Related]
2. Experimental phage therapy against haematogenous multi-drug resistant
Oduor JMO; Onkoba N; Maloba F; Nyachieo A
Afr J Lab Med; 2016; 5(1):435. PubMed ID: 28879116
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections.
Gupta R; Prasad Y
Curr Microbiol; 2011 Jan; 62(1):255-60. PubMed ID: 20607539
[TBL] [Abstract][Full Text] [Related]
4. Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2.
Hsieh SE; Lo HH; Chen ST; Lee MC; Tseng YH
Appl Environ Microbiol; 2011 Feb; 77(3):756-61. PubMed ID: 21148689
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice.
Sunagar R; Patil SA; Chandrakanth RK
Res Microbiol; 2010 Dec; 161(10):854-60. PubMed ID: 20868746
[TBL] [Abstract][Full Text] [Related]
6. Isolation and evaluation of the efficacy of bacteriophages against multidrug-resistant (MDR), methicillin-resistant (MRSA) and biofilm-producing strains of Staphylococcus aureus recovered from bovine mastitis.
Mohammadian F; Rahmani HK; Bidarian B; Khoramian B
BMC Vet Res; 2022 Nov; 18(1):406. PubMed ID: 36384653
[TBL] [Abstract][Full Text] [Related]
7. Experimental phage therapy against Staphylococcus aureus in mice.
Capparelli R; Parlato M; Borriello G; Salvatore P; Iannelli D
Antimicrob Agents Chemother; 2007 Aug; 51(8):2765-73. PubMed ID: 17517843
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Bacteriophages on the Metabolic Condition of Human Fibroblasts in Light of the Safety of Phage Therapy in Staphylococcal Skin Infections.
Kosznik-Kwaśnicka K; Stasiłojć M; Stasiłojć G; Kaźmierczak N; Piechowicz L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983034
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens.
Kvachadze L; Balarjishvili N; Meskhi T; Tevdoradze E; Skhirtladze N; Pataridze T; Adamia R; Topuria T; Kutter E; Rohde C; Kutateladze M
Microb Biotechnol; 2011 Sep; 4(5):643-50. PubMed ID: 21481199
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophage Therapy for the Prevention and Treatment of Fracture-Related Infection Caused by Staphylococcus aureus: a Preclinical Study.
Onsea J; Post V; Buchholz T; Schwegler H; Zeiter S; Wagemans J; Pirnay JP; Merabishvili M; D'Este M; Rotman SG; Trampuz A; Verhofstad MHJ; Obremskey WT; Lavigne R; Richards RG; Moriarty TF; Metsemakers WJ
Microbiol Spectr; 2021 Dec; 9(3):e0173621. PubMed ID: 34908439
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle.
Li L; Zhang Z
Mol Biol Rep; 2014 Sep; 41(9):5829-38. PubMed ID: 24981924
[TBL] [Abstract][Full Text] [Related]
12. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.
Matsuzaki S; Yasuda M; Nishikawa H; Kuroda M; Ujihara T; Shuin T; Shen Y; Jin Z; Fujimoto S; Nasimuzzaman MD; Wakiguchi H; Sugihara S; Sugiura T; Koda S; Muraoka A; Imai S
J Infect Dis; 2003 Feb; 187(4):613-24. PubMed ID: 12599078
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophage as effective decolonising agent for elimination of MRSA from anterior nares of BALB/c mice.
Chhibber S; Gupta P; Kaur S
BMC Microbiol; 2014 Aug; 14():212. PubMed ID: 25112504
[TBL] [Abstract][Full Text] [Related]
14. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.
Paul VD; Sundarrajan S; Rajagopalan SS; Hariharan S; Kempashanaiah N; Padmanabhan S; Sriram B; Ramachandran J
BMC Microbiol; 2011 Aug; 11():195. PubMed ID: 21880144
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus.
Kifelew LG; Warner MS; Morales S; Vaughan L; Woodman R; Fitridge R; Mitchell JG; Speck P
BMC Microbiol; 2020 Jul; 20(1):204. PubMed ID: 32646376
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.
Drilling A; Morales S; Jardeleza C; Vreugde S; Speck P; Wormald PJ
Am J Rhinol Allergy; 2014; 28(1):3-11. PubMed ID: 24717868
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains.
Kwiatek M; Parasion S; Mizak L; Gryko R; Bartoszcze M; Kocik J
Arch Virol; 2012 Feb; 157(2):225-34. PubMed ID: 22045271
[TBL] [Abstract][Full Text] [Related]
18. Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities.
Synnott AJ; Kuang Y; Kurimoto M; Yamamichi K; Iwano H; Tanji Y
Appl Environ Microbiol; 2009 Jul; 75(13):4483-90. PubMed ID: 19411410
[TBL] [Abstract][Full Text] [Related]
19. Strategy for mass production of lytic Staphylococcus aureus bacteriophage pSa-3: contribution of multiplicity of infection and response surface methodology.
Kim SG; Kwon J; Giri SS; Yun S; Kim HJ; Kim SW; Kang JW; Lee SB; Jung WJ; Park SC
Microb Cell Fact; 2021 Mar; 20(1):56. PubMed ID: 33653327
[TBL] [Abstract][Full Text] [Related]
20. Potential of bacteriophages as disinfectants to control of Staphylococcus aureus biofilms.
Song J; Ruan H; Chen L; Jin Y; Zheng J; Wu R; Sun D
BMC Microbiol; 2021 Feb; 21(1):57. PubMed ID: 33607940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
